BioCentury
ARTICLE | Company News

SeqWright Inc., Third Wave deal

January 8, 2007 8:00 AM UTC

SeqWright will perform sequencing and associated analyses for Phase III testing of two HPV in vitro diagnostic assays from TWTI (see BioCentury, Aug. 14, 2006). HPV HR 14 detects 14 high-risk types of...